Which science field has the most promising future?

Computer science
Nanotechnology
Biotechnology
Aerospace engineering
Ecology, resource saving
Cleantech
Other

What is the mankind's most dangerous invention?

Atomic bomb
Drugs
Automobile
Money
Television
Fast food
Internet

Biosset

BIOSSET Ltd. is a research-and-production company founded in 1994. Company develops, designs, produces innovative instruments for DNA and RNA synthesis.

Company′s mission is improving of people’s life by developing high-performance instruments for scientific and practical purposes based on latest achievements in molecular biology and biotechnologies.

The company has developed a range of DNA/RNA synthesizers: ASM-102U, ASM-700, ASM-800, ASM-1000, ASM-2000 and oligonucleotides purification systems OPS-201, OPS-1000. The production of the company is covered by patents of Russian Federation and registered trade marks.

Today BIOSSET is a leader at the Russian market and well-known competitor at the foreign market. It has been done more than 220 instruments with technical features that correspond to the best world-wide analogues Production of the company is in good demand from the researchers and successfully operates in 23 countries.

BIOSSET is a vertically integrated company that is working on whole cycle of instruments development: from idea to manufacture.

Contact details:
Address: 28, Ingenernaya street, Novosibirsk, 630090, Russia
Phone: + 7 383 330-3516, + 7 383 363- 5206
Fax: + 7 383 330-3516
E-mail: info@biosset.com
Web-site: http://www.biosset.com

Most popular news
Project search

Name of the project:

Research organization:

Industry:

Project type:

Amount of investment required, rubles:
-

Project duration:
-

Payback period (years)
-

Welcome to Investment. Innovation. Business Web Portal – a community-driven platform for all the participants of the investment process both in Russia and abroad!

We work to provide online information exchange between Russian and global investors and innovators, business owners and developers.